Rankings
▼
Calendar
▼
INBS Q3 2018 Earnings Report — Intelligent Bio Solutions Inc. Revenue & Financial Results | Market Cap Arena
Intelligent Bio Solutions Inc.
INBS
Q3 2018 Earnings
Reported March 31, 2018
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q3 2018
Q2 2018
Q3 2017
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$756.3K
-$1M
—
44.7%
—
EPS (Diluted)
$-178.50
$-436.90
—
59.1%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$708.6K
Selling & Marketing
$0
General & Administrative
$47.7K
SG&A Expenses
$47.7K
Other Expenses
$0
Operating Expenses
$756.3K
Cost & Expenses
$756.3K
OPERATING INCOME
-$756.3K
Interest Income
$141
Interest Expense
$98.7K
Other Income/Expenses
-$98.6K
INCOME BEFORE TAX
-$854.8K
Income Tax Expense
$0
Net Income from Continuing Ops
-$854.8K
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$839.6K
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$839.6K
D&A
$15.4K
EBIT
-$756.1K
EBITDA
-$756.1K
EPS
-$179
EPS Diluted
-$179
marketcaparena.com
← FY 2018
INBS Overview
Q2 2019 →